Dr. Rasheed A. Onafuye, M.D
Psychiatry (Geriatric Psychiatry Physician)
At a glance
- In the NPI registry since
- 2007
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2007Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Geriatric Psychiatry Physician primary
NC license 129145 -
Sleep Medicine (Psychiatry & Neurology) Physician
NC license 129145 · OK license 27941
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Buprenorphine Hcl Other prescribers in Monroe, NC | 70 |
| Clonazepam Other prescribers in Monroe, NC | 61 |
| Fluoxetine Hcl Other prescribers in Monroe, NC | 46 |
| Lamotrigine Other prescribers in Monroe, NC | 31 |
| Dextroamphetamine-Amphetamine (dextroamphetamine/amphetamine) Other prescribers in Monroe, NC | 25 |
| Bupropion Hcl Sr (bupropion hcl) Other prescribers in Monroe, NC | 18 |
| Zolpidem Tartrate Other prescribers in Monroe, NC | 17 |
| Alprazolam Other prescribers in Monroe, NC | 16 |
| Trazodone Hcl Other prescribers in Monroe, NC | 15 |
| Diazepam Other prescribers in Monroe, NC | 14 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 3 companies reported 6 payments worth $341 in total to this clinician.
| Neuronetics, Inc. | $302 |
|---|---|
| E.r. Squibb & Sons, L.l.c. | $20.62 |
| AbbVie Inc. | $18.72 |
| Food and Beverage | $341 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 3 industry-funded studies in 2025, from 2 companies. The companies reported $248,104 in research payments for these studies, mostly to the institutions running them.
- Proof of Concept and Dose-ranging Study of INDV-2000 in Individuals With Moderate to Severe Opioid Use Disorder
Indivior Inc. · Completed · NCT06384157 - Buprenorphine Extended-Release Subcutaneous Injection (RBP-6000) in High-risk Users
Indivior Inc. · Completed · NCT04995029 - A Study to Evaluate Efficacy, Safety, and Tolerability of Darigabat in Participants With Panic Disorder
AbbVie Inc. · Terminated · NCT05941442
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.